Lyophilized Synthetic Platelets: In Vitro Characterization and In Vivo Evaluation in Mouse Thrombocytopenia Model
Authors:
Open Access
- 20 April 2026
- journal article
- research article
- Published by Wiley in Advanced Science
- Vol. 13 (38) , e00002
Abstract
Platelet transfusions to treat bleeding complications use donor‐derived platelets stored at room‐temperature, that have a shelf‐life of only 5–7 days due to bacterial contamination risks. Cold‐stored and freeze‐dried platelets are being investigated for extending shelf‐life, but these still have the inherent challenge of donor‐dependency. To address this, we developed a liposome‐based synthetic platelet (SP) nanoconstruct that mimics the primary hemostatic mechanisms of platelets, and have previously reported its efficacy. However, a logistical limitation of SP is its susceptibility to environment‐induced physico‐chemical instabilities that reduces shelf‐life when stored as aqueous suspension, impacting its availability and bioactivity. Lyophilization of liposomal nanotherapeutics utilizing anhydrobiosis‐inspired lyoprotectants can enhance shelf‐life, but this has not been explored for synthetic platelets. With these considerations, we report advancing SP into a lyophilized product (Lyo‐SP) that can be rapidly aqueous‐reconstituted for on‐demand use. Lyo‐SP retained morphology, size, and charge in long‐term storage at various temperatures, and conserved platelet‐mimetic functions in multiparametric assays with human plasma and blood. Lyo‐SP demonstrated biosafety in its effect analysis on endothelial cells, neutrophils, RBCs and complement C3. Lyo‐SP significantly reduced bleeding in a tail‐clip model in thrombocytopenic mice. These studies establish the potential of Lyo‐SP as a shelf‐stable platelet surrogate for treating bleeding complications.Keywords
Funding Information
- National Center for Research Resources (C06 RR12463‐01)
- U.S. Department of War (W81XWH‐20‐1‐0628)
- U.S. Department of War (W81XWH‐17‐2‐0064)
This publication has 96 references indexed in Scilit:
- Biosynthetic blood surrogates: Current status and future opportunitiesBioengineering & Translational Medicine, 2025
- Lyophilized liposome-based parenteral drug development: Reviewing complex product design strategies and current regulatory environmentsAdvanced Drug Delivery Reviews, 2019
- The use of human umbilical vein endothelial cells (HUVECs) as an in vitro model to assess the toxicity of nanoparticles to endothelium: a reviewJournal of Applied Toxicology, 2017
- Thin-Film Hydration Followed by Extrusion Method for Liposome Preparation2016
- Long-Term Storage of Lyophilized Liposomal FormulationsJournal of Pharmaceutical Sciences, 2014
- TEG and ROTEM: Technology and clinical applicationsAmerican Journal of Hematology, 2014
- Well plate microfluidic system for investigation of dynamic platelet behavior under variable shear loadsBiotechnology and Bioengineering, 2011
- Affinity manipulation of surface-conjugated RGD peptide to modulate binding of liposomes to activated plateletsBiomaterials, 2008
- TNF Signaling in Vascular Endothelial CellsExperimental and Molecular Pathology, 2001
- Lyophilized Liposomes as Shelf Items for the Preparation of Immunogenic Liposome-Peptide ConjugatesAnalytical Biochemistry, 1993